Literature DB >> 7705658

Tissue-specific and allele-specific replication timing control in the imprinted human Prader-Willi syndrome region.

P H Gunaratne1, M Nakao, D H Ledbetter, J S Sutcliffe, A C Chinault.   

Abstract

To examine the relationship between replication timing and differential gene transcription in tissue-specific and imprinted settings we have studied the replication timing properties of the human Prader-Willi syndrome (PWS) region on human chromosome 15q11-13. Interphase fluorescence in situ hybridization with an overlapping series of cosmid clones was used to map a PWS replication timing domain to a 500- to 650-kb region that includes the SNRPN gene. This PWS domain replicates late in lymphocytes but predominantly early in neuroblasts, with replication asynchrony observed in both tissues, and appears to colocalize with a genetically imprinted transcription domain showing prominent expression in the brain. A 5- to 30-kb deletion in the 5' region of SNRPN results in the loss of late replication control of this domain in lymphocytes when the deleted chromosome is inherited paternally. This potential allele-specific replication timing control region also appears to colocalize with a putative imprinting control region that has been shown previously to abolish the expression of three imprinted transcripts in this same region.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705658     DOI: 10.1101/gad.9.7.808

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  11 in total

1.  Conserved characteristics of heterochromatin-forming DNA at the 15q11-q13 imprinting center.

Authors:  J M Greally; T A Gray; J M Gabriel; L Song; S Zemel; R D Nicholls
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Replication asynchrony increases in women at risk for aneuploid offspring.

Authors:  A Amiel; O Reish; E Gaber; I Kedar; R Diukman; M Fejgin
Journal:  Chromosome Res       Date:  2000       Impact factor: 5.239

3.  Duplication of 7p11.2-p13, including GRB10, in Silver-Russell syndrome.

Authors:  D Monk; E L Wakeling; V Proud; M Hitchins; S N Abu-Amero; P Stanier; M A Preece; G E Moore
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

4.  Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster.

Authors:  T Caspary; M A Cleary; C C Baker; X J Guan; S M Tilghman
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 5.  Genomic imprinting: a chromatin connection.

Authors:  R Feil; G Kelsey
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

6.  Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype.

Authors:  Matthew W State; John M Greally; Adam Cuker; Peter N Bowers; Octavian Henegariu; Thomas M Morgan; Murat Gunel; Michael DiLuna; Robert A King; Carol Nelson; Abigail Donovan; George M Anderson; James F Leckman; Trevor Hawkins; David L Pauls; Richard P Lifton; David C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

7.  Replication timing aberrations and aneuploidy in peripheral blood lymphocytes of breast cancer patients.

Authors:  Helena Grinberg-Rashi; Samuel Cytron; Zully Gelman-Kohan; Talia Litmanovitch; Lydia Avivi
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

8.  Replication status as a possible marker for genomic instability in cells originating from genotypes with balanced rearrangements.

Authors:  A Amiel; E Levi; O Reish; R Sharony; M D Fejgin
Journal:  Chromosome Res       Date:  2001       Impact factor: 5.239

9.  The aberrant asynchronous replication - characterizing lymphocytes of cancer patients - is erased following stem cell transplantation.

Authors:  Arnon Nagler; Samuel Cytron; Maya Mashevich; Avital Korenstein-Ilan; Lydia Avivi
Journal:  BMC Cancer       Date:  2010-05-24       Impact factor: 4.430

10.  Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients.

Authors:  Zohar A Dotan; Aviva Dotan; Jacob Ramon; Lydia Avivi
Journal:  BMC Cancer       Date:  2008-12-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.